Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 12 Head and Neck Neoplasms 3 Condylomata Acuminata 3 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Exanthema 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Warts 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Radiodermatitis 1 Parapsoriasis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Non-Melanoma Skin Cancers 1 Lymphoma, Follicular 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1

Interventions

testosterone undecanoate 2 testosterone 17 beta-cypionate 1 Testosterone 1 Gels 1 Drug Evaluation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Eunuchism × Gels × Clear all

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡